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Ferritin prevents calcification  
of vascular smooth muscle cells
Zarjou et al., J Am Soc Nephrol 2009; 20: 1254–1263; doi:10.1681/
ASN.2008070788
Patients with chronic kidney disease, who commonly exhibit 
hyperphosphatemia, can develop vascular calcifications faster than 
patients with any other clinical conditions. Two types of calcifica-
tion have been identified: (1) medial calcification, characterized 
by diffuse calcification of the media, particularly at the level of 
the internal elastic lamina, that does not necessarily accompany 
atherosclerosis; and (2) intimal calcification that occurs with 
atherosclerotic plaques. The mechanism of vascular calcification 
is not completely understood, although abnormalities in mineral 
metabolism (hyperphosphatemia) are considered important risk 
factors. The induction of smooth muscle cell (SMC) calcification 
and the observed osteochondrogenic phenotypic changes consist 
of a highly regulated cellular process involving many inducers and 
inhibitors of osteoblast–chondrocyte differentiation.
Zarjou and colleagues recently published a very interesting obser-
vation that the heme oxygenase 1 (HO-1)/ferritin system prevents 
inorganic phosphate (Pi)-mediated calcification and osteoblastic 
differentiation of human smooth muscle cells (HSMCs) in vitro. 
This group of investigators has demonstrated in the past the essen-
tial role of the HO-1/ferritin system to maintain homeostasis of 
vascular function. Now, they explore how far induction of HO-1/
ferritin could alter the mineralization of HSMCs stimulated by high 
serum Pi levels. Upregulation of the HO-1/ferritin system inhibited 
HSMC calcification and osteoblastic differentiation. Of the products 
of this system, only ferritin and, to a lesser extent, biliverdin were 
responsible for the inhibition. Ferritin heavy chain and ceruloplas-
min, which both possess ferroxidase activity, inhibited calcification. 
A site-directed mutant of ferritin heavy chain, which lacked ferroxi-
dase activity, failed to inhibit calcification. In addition, osteoblastic 
transformation of HSMCs provoked by elevated Pi (assessed by 
upregulation of core binding factor α-1, osteocalcin, and alkaline 
phosphatase activity) was diminished by ferritin/ferroxidase activ-
ity. This report demonstrates for the first time a role for ferritin in 
regulating high-Pi-induced HSMC mineralization.
This study is limited to very well-controlled in vitro observations. 
In vivo experiments using an appropriate animal model are needed 
to make these intriguing observations relevant to the clinical prob-
lem of vascular calcifications in patients and a well-documented 
correlation with mortality in dialysis. In addition, these in vitro 
results could help to explain the iron overload–adynamic bone 
relationship described more than 25 years ago in dialysis patients, 
as well as other clinical conditions of iron overload (for example, 
thalassemia) associated with decreased osteoblastic activity and 
mineralization.
Marc De Broe
Atrial natriuretic peptide and 
dehydration-induced natriuresis
Chen et al., J Clin Invest 2009; 119: 1647–1658; doi:10.1172/JCI35314
Under normal conditions, extracellular sodium concentration 
is fundamentally controlled by regulation of water metabolism. 
During water deprivation or excessive water loss, as extracellu-
lar sodium and plasma tonicity rise, thirst is activated and vaso-
pressin is secreted from the neurohypophysis. However, it has 
long been known that initially water deprivation induces natriu-
resis so that water depletion also results in a decrease in sodium 
content. This response has been termed dehydration natriuresis, 
and it is believed to be important in preventing further increases 
in extracellular tonicity. Previous investigations have suggested a 
variety of mechanisms for dehydration natriuresis, but the actual 
mechanism remains unexplained. Increased extracellular tonic-
ity in the renal medulla increases the expression of many genes, 
including those of aldose reductase, the betaine/γ-aminobutyric 
acid transporter, taurine transporter, heat-shock protein-70, the 
sodium/myo-inositol cotransporter, the urea transporters, and 
aquaporin 2. In all these examples, an increase in gene expression 
is due to a rise in gene transcription mediated through a tonicity-
responsive enhancer (TonE) element in the promoter region of the 
gene. The TonE-binding protein (TonEBP) belongs to the family 
of nuclear factor of activated T cell nuclear transcription factors 
(NFATs) and was assigned the name NFAT5. In the basal state, 
TonEBP/NFAT5 is distributed in both the nucleus and the cyto-
plasm of the cell. But in a hypertonic environment, it translocates 
selectively into the nuclear compartment. Medullary hypertonicity 
also increases expression of the type A natriuretic peptide recep-
tor (NPR-A), a receptor that binds both atrial natriuretic pep-
tide and the B-type natriuretic peptide, thereby increasing renal 
sodium excretion. In a recent publication, Chen et al. examined the 
mechanism whereby NPR-A increases in response to hypertonic-
ity. They focused on serum- and glucocorticoid-regulated kinase 
1 (Sgk1), a kinase that is highly expressed in the renal medulla and 
induced by a variety of stimuli, including serum, glucocorticoids, 
transcription growth factor-β, aldosterone, and increased extracel-
lular tonicity. They found a TonE upstream of the Sgk1 transcrip-
tional start site. Also, TonEBP/NFAT5 associated with TonE in a 
tonicity-dependent fashion in cultured renal medullary cells, and 
selective blockade of NFAT5 activity suppressed the osmotic induc-
tion of the Sgk1 promoter. In vivo, water restriction increased urine 
osmolality, Sgk1 expression, expression of NPR-A, and dehydration 
Human smooth muscle cells were cultured in normal growth medium 
(a) or in calcification medium in the absence (b) or presence (c) of heme  
(50 µmol/l) for 9 days. von Kossa staining of cells was performed. 
Representative pictures of three separate experiments.
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natriuresis. Sgk1 knockdown mediated by small interfering RNA 
blocked the osmotic induction of NPR-A gene (Npr1) expression. 
Importantly, NPR-A gene–deleted (Npr1–/–) mice were resistant 
to dehydration natriuresis (Figure). These results show that NPR1 
is critical for dehydration natriuresis and indicate that Sgk1 plays 
an important role in promoting the physiological response of the 
kidney to elevations in extracellular tonicity.
Juan Oliver
FGF-23 and left ventricular 
hypertrophy in CKD
Gutiérrez et al., Circulation 2009; 119: 2545–2552; doi:10.1161/
CIRCULATIONAHA.108.844506
Fibroblast growth factor 23 (FGF-23) is a hormone thought to play 
a mechanistic role in the relationship between serum phosphate, 
vitamin D levels, and mortality. It increases urinary excretion of 
phosphate and inhibits production of 1,25-dihydroxyvitamin D 
by the kidney. In this manner, it is one of the body’s responses to 
hyperphosphatemia in chronic kidney disease (CKD).
Gutiérrez et al. demonstrated an association between greater 
FGF-23 levels and mortality in a prospective cohort of 10,044 patients 
who were beginning hemodialysis. Greater FGF-23 levels were asso-
ciated with an increasing mortality. To examine the potential corre-
lates of FGF-23 with structural and functional changes of the heart, 
the investigators hypothesized that elevated FGF-23 concentrations 
are associated with left ventricular hypertrophy (LVH) and coro-
nary artery calcification.1 In all, 162 patients with CKD underwent 
echocardiograms and computed tomography. A separate cohort of 
58 subjects without CKD was also enrolled and underwent echocar-
diograms. Greater FGF-23 values were independently associated 
with increased left ventricular mass index and risk of LVH. This 
relationship was slightly greater in subjects with CKD alone. While 
the relationship between FDF-23 and LVH was significant and dose-
related, its relationship with coronary artery calcification was not as 
strong. Subjects in the highest tertile of FGF-23 had an increased risk 
of coronary artery calcification, ≥100 versus <100 U, compared with 
the lowest tertile. However, this association was no longer significant 
after adjustment for numerous clinical and demographic variables.
The late development of abnormalities in serum calcium and 
phosphorus among people with CKD makes these laboratory tests 
inadequate to truly assess CKD patients at risk for the development 
of cardiovascular disease related to disordered mineral metabolism.2 
However, a role for disordered calcium and phosphate metabolism 
in the increased risk of morbidity and mortality in patients with 
CKD and end-stage renal disease is clear. Further, the association 
between FGF-23 and the structural changes of heart disease clearly 
supports the hypothesis that it could be a valid surrogate outcome. 
FGF-23 could be the marker for the treatment of abnormal cal-
cium and phosphorus metabolism before calcium and phosphorus 
together or individually are found to be abnormal.
Lynda Szczech
1N Engl J Med 2008; 359: 584–592. 2Kidney Int 2007; 71: 31–38.
Multiple loci associated  
with renal function and CKD
Köttgen et al., Nat Genet 2009; 41: 712–717; doi:10.1038/ng.377
Chronic kidney disease (CKD) affects 10%–15% of adults. Multiple 
studies, such as familial aggregation studies, have suggested a genetic 
component to kidney function and disease. Heritability estimates of 
glomerular filtration rate, estimated by serum creatinine, are reported 
between 0.41 and 0.75 in individuals with the major CKD risk fac-
tor of hypertension or diabetes, and as 0.33 in a population-based 
sample. Rare genetic variants causing different forms of monogenetic 
kidney disease have been identified, but common CKD susceptibil-
ity variants have been difficult to detect by linkage or candidate-
gene studies. To discover such variants, Köttgen et al. conducted 
meta-analyses of study-specific genome-wide association studies 
for indexes of renal function—glomerular filtration rate estimated 
by serum creatinine (eGFRcrea) and cystatin C (eGFRcys)—and 
for CKD (eGFRcrea < 60 ml/min/1.73 m2). They examined four 
population-based, unselected cohorts of the Cohorts for Heart and 
Aging Research in Genomic Epidemiology (CHARGE) Consor-
tium: Atherosclerosis Risk in Communities Study, Cardiovascular 
Health Study, Framingham Heart Study, and Rotterdam Study, all 
with subjects of European ancestry. Genome-wide association stud-
ies to identify susceptibility loci were conducted in 19,877 subjects 
(2,388 CKD cases) and tested for replication in 21,466 participants 
(1,932 CKD cases). They identified significant single-nucleotide poly-
morphism associations (P < 5 × 10–8) with CKD at the UMOD locus, 
with eGFRcrea at UMOD, SHROOM3, and GATM-SPATA5L1, and 
with eGFRcys at CST and STC1. UMOD encodes the most common 
protein in human urine, Tamm-Horsfall protein, and mutations in 
UMOD cause rare mendelian forms of kidney disease: medullary 
cystic kidney disease type 2, familial juvenile hyperuricemic nephro-
pathy, and glomerulocystic kidney disease. In addition, mice with 
deleted UMOD had lower creatinine clearance than wild-type mice. It 
is thus apparent that studies to understand the production and func-
tions of Tamm-Horsfall protein are warranted. This work identifies 
and validates common variants at several previously unknown loci 
conferring susceptibility for kidney dysfunction and CKD in large, 
unselected population-based studies. These results also provide new 
insights into CKD pathogenesis and underscore the importance of 
common genetic variants influencing renal function and disease.
Juan Oliver 
Effect of water restriction (Dehy) on the natriuresis of wild-type and Npr1–/– mice. 
C, control; UNa V, urine sodium excretion rate. **P < 0.001 vs. control.
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